Regulation of dihydropyridine calcium antagonist binding sites in the rat hippocampus following neurochemical lesions.

The effects of catecholaminergic, cholinergic, serotonergic, and glutaminergic terminal destruction and neurotransmitter depletion on [3H]nitrendipine binding to rat brain membranes were determined using the neurotoxins 6-hydroxydopamine, 5,7-dihydroxytryptamine, and kainic acid and the neurotransmitter-depleting agent reserpine. Following intracisternal injection of 6-hydroxydopamine there were time-dependent increases (14-23%) in the density but not change in the affinity of hippocampal [3H]nitrendipine binding sites. 6-Hydroxydopamine significantly increased [3H]nitrendipine binding in the hippocampus 4 and 10 days following injection. However, no significant change in binding was observed at 16 and 26 days. [3H]Nitrendipine binding in the cerebral cortex, striatum, cerebellum, and brain stem was unaffected by 6-hydroxydopamine. Neither 5,7-dihydroxytryptamine nor kainic acid affected [3H]nitrendipine binding in the hippocampus and cerebral cortex. Acute and chronic reserpinization also did not affect [3H]nitrendipine binding in the hippocampus and cerebral cortex. These results indicate that dihydropyridine calcium antagonist bindings sites in rat brain are subject to brain region-specific regulation following neurochemical lesions and may be present in their largest densities on postsynaptic membranes.

[3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters.

Saturable and stereoselective binding sites for [3H]threo-(+/-)-methylphenidate were characterized in rat brain membranes. The highest density of [3H]threo-(+/-)-methylphenidate binding sites was found in the synaptosomal fraction of corpus striatum. Scatchard analysis revealed a single class of noninteracting binding sites with an apparent dissociation constant (KD) of 235 nM and a maximum number of binding sites (Bmax) of 13.4 pmol/mg protein. Saturable, high-affinity binding of [3H]threo-(+/-)-methylphenidate to striatal synaptosomal membranes was dependent on the presence of sodium ions. A good correlation (r = 0.88; p less than 0.001) was observed between the potencies of various psychotropic drugs in displacing [3H]threo-(+/-)-methylphenidate from these sites and their potencies as inhibitors of [3H]3,4-dihydroxyphenylethylamine ( [3H]dopamine) uptake into striatal synaptosomes. A good correlation (r = 0.85; p less than 0.001) was also observed between the potencies of a series of ritalinic acid esters in inhibiting [3H]threo-(+/-)-methylphenidate binding to striatal synaptosomal membranes and their potencies as motor stimulants in mice. These observations suggest that the binding sites for [3H]threo-(+/-)-methylphenidate described here are associated with a dopamine uptake or transport complex, and that these sites may mediate the motor stimulant properties of ritalinic acid esters such as methylphenidate.

Regulation of noradrenergic receptor systems in brain that are coupled to adenylate cyclase.

The current status of regulation of norepinephrine (NE) receptor systems in brain that are coupled to adenylate cyclase is briefly reviewed. The availability of NE and the formation of the NE receptor complex is one prerequisite for the regulation of both the sensitivity of the system and the density of its beta-adrenoceptor population. Serotonergic neuronal input is corequired with NE for the down-regulation of the number of beta-adrenoceptors, which in the absence of serotonergic input, show a marked decrease in agonist affinity. Steroid hormones influence either the sensitivity of the NE receptor system (adrenocorticoids) or the biological responsiveness and the density of beta-adrenoceptors (sex steroids) while preliminary data indicate that 3,5,3'-triiodothyronine can convert a "DMI resistant" to a "DMI responsive" receptor system. The complex neurohormonal and endocrine regulation of the biological responsiveness of NE receptor systems, the number of receptors and the efficacy of their coupling to adenylate cyclase appear to represent control mechanisms for the intensity of signal transfer.

Human serum alpha-L-fucosidase.

Human serum alpha-L-fucosidase has been purified 241 200-fold with 35% yield by an affinity chromatographic procedure utilizing agarose-epsilon-aminocaproyl-fucosamine. Isoelectric focusing of the purified enzyme indicated the presence of several forms, with the form at pI 5.0 comprising the majority of the activity. Assay of the purified alpha-L-fucosidase showed only trace amounts of contaminating glycosidases present, with beta-galactosidase being the largest contamnant (0.5% by activity). Sodium dodecyl sulfate polyacrylamide gel electrophoresis indicated the presence of two subunits with very similar molecular weights (56 500 and 54 000). Using the p-nitrophenyl substrate, the purified serum alpha-L-fucosidase has an apparent Michaelis constant of 0.52 mM and a broad pH optimum centered around pH 4.8 with a second, minor optimum at pH 6.1. Gel filtration on Sepharose 6-B indicated an apparent molecular weight of 296 000 +/- 30 000. Preincubation with antibodies made previously against purified liver alpha-L-fucosidase led to quantitative immunoprecipitation of the purified serum alpha-L-fucosidase. Assay of the purified serum alpha-L-fucosidase for sialic acid indicated the presence of 1.7 microgram sialic acid per 100 microgram enzyme, about twice that previously found for the purified liver enzyme.